[1]
|
Baig, S.A. and Baig, M.N. (2018) Osteonecrosis of the Femoral Head: Etiology, Investigations, and Management. Cureus, 10, e3171. https://doi.org/10.7759/cureus.3171
|
[2]
|
Liu, Y.F., Chen, W.M., Lin, Y.F., et al. (2005) Type II Collagen Gene Variants and Inherited Osteonecrosis of the Femoral Head. New England Journal of Medicine, 352, 2294-2301. https://doi.org/10.1056/NEJMoa042480
|
[3]
|
Zhang, Y., Wang, K., Song, Q., et al. (2014) Role of the Local Bone Renin-Angiotensin System in Steroid-Induced Osteonecrosis in Rabbits. Molecular Medicine Reports, 9, 1128-1134. https://doi.org/10.3892/mmr.2014.1978
|
[4]
|
Zhang, Y., Zhao, Z., Wang, C., et al. (2019) Association between the Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Avascular Necrosis of the Femoral Head. Genetic Testing and Molecular Biomarkers, 23, 778-782. https://doi.org/10.1089/gtmb.2019.0068
|
[5]
|
刘保一, 李敏德, 杨帆, 等. 血管紧张素II可促进小鼠激素诱导的缺血性股骨头坏死[J]. 中国组织工程研究, 2019, 23(19): 3044-3049.
|
[6]
|
Zhao, J., Yang, H., Chen, B., et al. (2019) The Skeletal Renin-Angiotensin System: A Potential Therapeutic Target for the Treatment of Osteoarticular Diseases. International Immunopharmacology, 72, 258-263.
https://doi.org/10.1016/j.intimp.2019.04.023
|
[7]
|
Wu, Y., Li, M., Zeng, J., et al. (2020) Differential Expression of Renin-Angiotensin System-Related Components in Patients with Rheumatoid Arthritis and Osteoarthritis. The American Journal of the Medical Sciences, 359, 17-26.
https://doi.org/10.1016/j.amjms.2019.10.014
|
[8]
|
Gebru, Y., Diao, T.Y., Pan, H., et al. (2013) Potential of RAS Inhibition to Improve Metabolic Bone Disorders. BioMed Research International, 2013, Article ID: 932691. https://doi.org/10.1155/2013/932691
|
[9]
|
Izu, Y., Mizoguchi, F., Kawamata, A., et al. (2009) Angiotensin II Type 2 Receptor Blockade Increases Bone Mass. Journal of Biological Chemistry, 284, 4857-4864. https://doi.org/10.1074/jbc.M807610200
|
[10]
|
Wang, Y., Kou, J., Zhang, H., et al. (2018) The Renin-Angiotensin System in the Synovium Promotes Periarticular Osteopenia in a Rat Model of Collagen-Induced Arthritis. International Immunopharmacology, 65, 550-558.
https://doi.org/10.1016/j.intimp.2018.11.001
|
[11]
|
Braz, N., Pinto, M., Vieira, E., et al. (2020) Renin-Angiotensin System Molecules Are Associated with Subclinical Atherosclerosis and Disease Activity in Rheumatoid Arthritis. Modern Rheumatology, 1-8.
https://doi.org/10.1080/14397595.2020.1740418
|
[12]
|
Carbone, L.D., Vasan, S., Prentice, R.L., et al. (2019) The Renin-Angiotensin Aldosterone System and Osteoporosis: Findings from the Women’s Health Initiative. Osteoporosis International, 30, 2039-2056.
https://doi.org/10.1007/s00198-019-05041-3
|
[13]
|
Kao, Y.T., Huang, C.Y., Fang, Y.A., et al. (2020) The Association between Renin Angiotensin Aldosterone System Blockers and Future Osteoporotic Fractures in a Hypertensive Population—A Population-Based Cohort Study in Taiwan. International Journal of Cardiology, 305, 147-153. https://doi.org/10.1016/j.ijcard.2019.12.069
|
[14]
|
Lin, T.T., Wu, C.K., Liao, M.T., et al. (2017) Primary Prevention of Myocardial Infarction with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertensive Patients with Rheumatoid Arthritis—A Nationwide Cohort Study. PLoS ONE, 12, e188720. https://doi.org/10.1371/journal.pone.0188720
|
[15]
|
Abuohashish, H.M., Ahmed, M.M., Sabry, D., et al. (2017) ACE-2/Ang1-7/Mas Cascade Mediates Ace Inhibitor, Captopril, Protective Effects in Estrogen-Deficient Osteoporotic Rats. Biomedicine & Pharmacotherapy, 92, 58-68.
https://doi.org/10.1016/j.biopha.2017.05.062
|
[16]
|
Nakagami, H. and Morishita, R. (2009) Hormones and Osteoporosis Update. Effect of Angiotensin II on Bone Metabolism. Clinical Calcium, 19, 997-1002.
|
[17]
|
Coughlan, T. and Dockery, F. (2014) Osteoporosis and Fracture Risk in Older People. Clinical Medicine, 14, 187-191.
https://doi.org/10.7861/clinmedicine.14-2-187
|
[18]
|
Hatton, R., Stimpel, M. and Chambers, T.J. (1997) Angiotensin II Is Generated from Angiotensin I by Bone Cells and Stimulates Osteoclastic Bone Resorption in Vitro. Journal of Endocrinology, 152, 5-10.
https://doi.org/10.1677/joe.0.1520005
|
[19]
|
Shimizu, H., Nakagami, H. and Morishita, R. (2012) Activation of Osteoclasts by RAAS and Strategy of Target Therapy on Bone Metabolic Diseases. Nihon Rinsho, 70, 1524-1529.
|
[20]
|
Zhang, Y.T., et al. (2014) Glucocorticoids Activate the Local Renin-Angiotensin System in Bone: Possible Mechanism for Glucocorticoid-Induced Osteoporosis. Endocrine, 47, 598-608. https://doi.org/10.1007/s12020-014-0196-z
|
[21]
|
Asaba, Y., Ito, M., Fumoto, T., et al. (2009) Activation of Renin-Angiotensin System Induces Osteoporosis Independently of Hypertension. Journal of Bone and Mineral Research, 24, 241-250. https://doi.org/10.1359/jbmr.081006
|
[22]
|
Zhou, F., Rong, C., Wang, K., et al. (2016) Investigation on the Role on Perindopril for Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Rabbits. China Journal of Orthopaedics and Traumatology, 29, 52-57.
|
[23]
|
Lynn, H., Kwok, T., Wong, S.Y., et al. (2006) Angiotensin Converting Enzyme Inhibitor Use Is Associated with Higher Bone Mineral Density in Elderly Chinese. Bone, 38, 584-588. https://doi.org/10.1016/j.bone.2005.09.011
|
[24]
|
Amin, N., Boccardi, V., Taghizadeh, M., et al. (2020) Probiotics and Bone Disorders: The Role of RANKL/ RANK/OPG Pathway. Aging Clinical and Experimental Research, 32, 363-371.
https://doi.org/10.1007/s40520-019-01223-5
|
[25]
|
Liu, W. and Zhang, X. (2015) Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL)/RANK/Osteoprotegerin System in Bone and Other Tissues (Review). Molecular Medicine Reports, 11, 3212-3218.
https://doi.org/10.3892/mmr.2015.3152
|
[26]
|
Shimizu, H., Nakagami, H., Osako, M.K., et al. (2008) Angiotensin II Accelerates Osteoporosis by Activating Osteoclasts. FASEB Journal, 22, 2465-2475. https://doi.org/10.1096/fj.07-098954
|
[27]
|
Tanaka, T., Kelly, M., Takei, Y., et al. (2018) RANKL-Mediated Osteoclastogenic Differentiation of Macrophages in the Abdominal Aorta of Angiotensin II-Infused Apolipoprotein E Knockout Mice. Journal of Vascular Surgery, 68, 48S-59S. https://doi.org/10.1016/j.jvs.2017.11.091
|
[28]
|
Jiang, Y., Zhang, Y., Chen, W., et al. (2014) Achyranthesbidentata Extract Exerts Osteoprotective Effects on Steroid-Induced Osteonecrosis of the Femoral Head in Rats by Regulating RANKL/RANK/OPG Signaling. Journal of Translational Medicine, 12, 334. https://doi.org/10.1186/s12967-014-0334-7
|
[29]
|
Kim, H.K., Morgan-Bagley, S. and Kostenuik, P. (2006) RANKL Inhibition: A Novel Strategy to Decrease Femoral Head Deformity after Ischemic Osteonecrosis. Journal of Bone and Mineral Research, 21, 1946-1954.
https://doi.org/10.1359/jbmr.060905
|
[30]
|
Mont, M.A., Salem, H.S., Piuzzi, N.S., et al. (2020) Nontraumatic Osteonecrosis of the Femoral Head: Where Do We Stand Today? A 5-Year Update. The Journal of Bone and Joint Surgery. American Volume.
https://doi.org/10.2106/JBJS.19.01271
|
[31]
|
Shah, K.N., Racine, J., Jones, L.C., et al. (2015) Pathophysiology and Risk Factors for Osteonecrosis. Current Reviews in Musculoskeletal Medicine, 8, 201-209. https://doi.org/10.1007/s12178-015-9277-8
|
[32]
|
Nakagami, H., Osako, M.K. and Morishita, R. (2013) Potential Effect of Angiotensin II Receptor Blockade in Adipose Tissue and Bone. Current Pharmaceutical Design, 19, 3049-3053. https://doi.org/10.2174/1381612811319170011
|
[33]
|
Wassmann, S. and Nickenig, G. (2006) Pathophysiological Regulation of the AT1-Receptor and Implications for Vascular Disease. Journal of hypertension. Supplement, 24, S15-S21. https://doi.org/10.1097/01.hjh.0000220402.53869.72
|
[34]
|
Pacurari, M., Kafoury, R., Tchounwou, P.B., et al. (2014) The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling. International Journal of Inflammation, 2014, Article ID: 689360.
https://doi.org/10.1155/2014/689360
|
[35]
|
Lykissas, M.G., Gelalis, I.D., Kostas-Agnantis, I.P., et al. (2012) The Role of Hypercoagulability in the Development of Osteonecrosis of the Femoral Head. Orthopedic Reviews (Pavia), 4, e17. https://doi.org/10.4081/or.2012.e17
|
[36]
|
Zhang, W., Zhao, H., Peng, X., et al. (2011) Low-Dose Captopril Inhibits Wear Debris-Induced Inflammatory Osteolysis. Journal of International Medical Research, 39, 798-804. https://doi.org/10.1177/147323001103900312
|
[37]
|
康鹏德, 沈彬, 杨静, 等. 抗凝、降脂治疗对预防兔激素型股骨头缺血性坏死的实验研究[J]. 中华关节外科杂志(电子版), 2007(1): 56-61.
|
[38]
|
Wang, C., Zhang, C., Zhou, F., et al. (2018) Angiotensin II Induces Monocyte Chemoattractant Protein1 Expression by Increasing Reactive Oxygen Speciesmediated Activation of the Nuclear Factor kappaB Signaling Pathway in Osteoblasts. Molecular Medicine Reports, 17, 1166-1172. https://doi.org/10.3892/mmr.2017.7971
|
[39]
|
Strawn, W.B. (2002) Pathophysiological and Clinical Implications of AT(1) and AT(2) Angiotensin II Receptors in Metabolic Disorders: Hypercholesterolaemia and Diabetes. Drugs, 62, 31-41.
https://doi.org/10.2165/00003495-200262991-00004
|
[40]
|
翟玥, 邓国英, 王秋根, 等. 活性氧与激素性股骨头坏死[J]. 国际骨科学杂志, 2017, 38(2): 102-105.
|
[41]
|
Olatunji, L.A., Usman, T.O., Seok, Y.M., et al. (2017) Activation of Cardiac Renin-Angiotensin System and Plasminogen Activator Inhibitor-1 Gene Expressions in Oral Contraceptive-Induced Cardiometabolic Disorder. Archives of Physiology and Biochemistry, 123, 1-8. https://doi.org/10.3109/13813455.2016.1160935
|
[42]
|
刘金鑫, 张方怡, 张岩. 血管紧张素II调控骨代谢的研究进展[J]. 中国药理学通报, 2015, 31(4): 458-461.
|
[43]
|
Queiroz-Junior, C.M., Santos, A., Galvao, I., et al. (2019) The Angiotensin Converting Enzyme 2/Angiotensin- (1-7)/Mas Receptor Axis as a Key Player in Alveolar Bone Remodeling. Bone, 128, Article ID: 115041.
https://doi.org/10.1016/j.bone.2019.115041
|
[44]
|
Abuohashish, H.M., Ahmed, M.M., Sabry, D., et al. (2017) Angiotensin (1-7) Ameliorates the Structural and Biochemical Alterations of Ovariectomy-Induced Osteoporosis in Rats via Activation of ACE-2/Mas Receptor Axis. Scientific Reports, 7, Article No. 2293. https://doi.org/10.1038/s41598-017-02570-x
|
[45]
|
Abuohashish, H.M., Ahmed, M.M., Sabry, D., et al. (2017) The ACE-2/Ang1-7/Mas Cascade Enhances Bone Structure and Metabolism Following Angiotensin-II Type 1 Receptor Blockade. European Journal of Pharmacology, 807, 44-55. https://doi.org/10.1016/j.ejphar.2017.04.031
|
[46]
|
Diao, T.Y., Pan, H., Gu, S.S., et al. (2014) Effects of Angiotensin-Converting Enzyme Inhibitor, Captopril, on Bone of Mice with Streptozotocin-Induced Type 1 Diabetes. Journal of Bone and Mineral Metabolism, 32, 261-270.
https://doi.org/10.1007/s00774-013-0500-7
|
[47]
|
吴元刚, 沈彬, 曾羿. 肾素–血管紧张素系统在骨关节炎发病中的研究[J]. 中华关节外科杂志(电子版), 2019, 13(4): 448-454.
|
[48]
|
Zhang, Y., Li, X.L., Sha, N.N., et al. (2017) Differential Response of Bone and Kidney to ACEI in db/db Mice: A Potential Effect of Captopril on Accelerating Bone Loss. Bone, 97, 222-232. https://doi.org/10.1016/j.bone.2017.01.029
|